1. Home
  2. CTKB vs IFN Comparison

CTKB vs IFN Comparison

Compare CTKB & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • IFN
  • Stock Information
  • Founded
  • CTKB 1990
  • IFN 1993
  • Country
  • CTKB United States
  • IFN Singapore
  • Employees
  • CTKB N/A
  • IFN N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IFN Finance/Investors Services
  • Sector
  • CTKB Health Care
  • IFN Finance
  • Exchange
  • CTKB Nasdaq
  • IFN Nasdaq
  • Market Cap
  • CTKB 708.8M
  • IFN 644.0M
  • IPO Year
  • CTKB 2021
  • IFN N/A
  • Fundamental
  • Price
  • CTKB $6.27
  • IFN $16.18
  • Analyst Decision
  • CTKB Strong Buy
  • IFN
  • Analyst Count
  • CTKB 3
  • IFN 0
  • Target Price
  • CTKB $9.17
  • IFN N/A
  • AVG Volume (30 Days)
  • CTKB 646.8K
  • IFN 135.2K
  • Earning Date
  • CTKB 11-05-2024
  • IFN 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • IFN 8.68%
  • EPS Growth
  • CTKB N/A
  • IFN N/A
  • EPS
  • CTKB N/A
  • IFN N/A
  • Revenue
  • CTKB $201,210,000.00
  • IFN N/A
  • Revenue This Year
  • CTKB $8.18
  • IFN N/A
  • Revenue Next Year
  • CTKB $13.21
  • IFN N/A
  • P/E Ratio
  • CTKB N/A
  • IFN N/A
  • Revenue Growth
  • CTKB 9.88
  • IFN N/A
  • 52 Week Low
  • CTKB $4.66
  • IFN $14.40
  • 52 Week High
  • CTKB $9.87
  • IFN $21.25
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 45.80
  • IFN 26.45
  • Support Level
  • CTKB $6.11
  • IFN $17.22
  • Resistance Level
  • CTKB $6.78
  • IFN $17.28
  • Average True Range (ATR)
  • CTKB 0.33
  • IFN 0.26
  • MACD
  • CTKB -0.09
  • IFN -0.09
  • Stochastic Oscillator
  • CTKB 13.95
  • IFN 10.13

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About IFN India Fund Inc. (The)

India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.

Share on Social Networks: